These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 125803)

  • 21. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.
    Yamaoka M; Hara T; Hitaka T; Kaku T; Takeuchi T; Takahashi J; Asahi S; Miki H; Tasaka A; Kusaka M
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):115-28. PubMed ID: 22249003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relations between circulating levels of testosterone, 17 beta-estradiol, androstenedione, dehydroepiandrosterone sulfate, and androgenic receptor content of cytosol in benign prostatic hyperplasia.
    Corrales Hernández JJ; Miralles García JM; Hoisaeter PA; Martin T; García Diez LC; Montero Gómez J
    Urol Int; 1983; 38(2):109-15. PubMed ID: 6189274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacia Award 1990. The biological significance of low testosterone levels and of adrenal androgens in transplantable prostate cancer lines.
    van Weerden WM; van Kreuningen A; Moerings EP; de Jong FH; van Steenbrugge GJ; Schröder FH
    Urol Res; 1991; 19(1):1-5. PubMed ID: 1827556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orchiectomy does not selectively increase adrenal androgen concentrations.
    Parker L; Lai M; Wolk F; Lifrak E; Kim S; Epstein L; Hadley D; Miller J
    J Clin Endocrinol Metab; 1984 Sep; 59(3):547-50. PubMed ID: 6235240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endocrinological studies on prostatic carcinoma. 1. Plasma hormone profiles in patients with prostatic carcinoma (author's transl)].
    Morioka M
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):953-66. PubMed ID: 6459486
    [No Abstract]   [Full Text] [Related]  

  • 26. Variations in circulating sex steroid levels in metastatic prostate cancer patients with combined androgen blockade: observation and implication.
    Qin X; Zhang H; Ye D; Yao X; Zhang S; Dai B
    Andrology; 2013 May; 1(3):512-6. PubMed ID: 23536478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy.
    Mafla-España MA; Torregrosa MD; Beamud-Cortés M; Bermell-Marco L; Rubio-Briones J; Cauli O
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advantages of total androgen blockade in the treatment of advanced prostate cancer.
    Geller J; Albert J; Vik A
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):53-61. PubMed ID: 3285484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal therapy of prostate cancer.
    Labrie F
    Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients.
    Miyazawa Y; Sekine Y; Syuto T; Nomura M; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
    BMC Urol; 2017 Aug; 17(1):70. PubMed ID: 28851333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry.
    van der Sluis TM; Bui HN; Meuleman EJ; Heijboer AC; Hartman JF; van Adrichem N; Boevé E; de Ronde W; van Moorselaar RJ; Vis AN
    J Urol; 2012 May; 187(5):1601-6. PubMed ID: 22425112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
    Mostaghel EA; Page ST; Lin DW; Fazli L; Coleman IM; True LD; Knudsen B; Hess DL; Nelson CC; Matsumoto AM; Bremner WJ; Gleave ME; Nelson PS
    Cancer Res; 2007 May; 67(10):5033-41. PubMed ID: 17510436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
    Ryan CJ; Halabi S; Ou SS; Vogelzang NJ; Kantoff P; Small EJ
    Clin Cancer Res; 2007 Apr; 13(7):2030-7. PubMed ID: 17404083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment].
    Oka H; Negoro H; Sugino Y; Iwamura H; Moroi S; Kawakita M
    Hinyokika Kiyo; 2003 Sep; 49(9):521-5. PubMed ID: 14598689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinoma.
    Geller J
    Urol Clin North Am; 1991 Feb; 18(1):83-91. PubMed ID: 1825145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adrenal androgens and circulating 17 beta-estradiol/testosterone ratio in benign hyperplasia of the prostate].
    Corrales Hernández JJ; García Díez LC; Martín Rodríguez M; Montero Gómez J; Miralles García JM
    Med Clin (Barc); 1984 May; 82(17):751-3. PubMed ID: 6204173
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Hormones, elderly testes, and carcinoma of the prostate.
    Habib FK; Stitch SR
    Br Med J; 1975 Dec; 4(5997):650. PubMed ID: 54202
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of plasma androgen levels with a combination therapy of depot-estrogen (Turisteron) and Dexamethasone in patients with prostatic cancer.
    Stahl F; Schnorr D; Bär CM; Fröhlich G; Dörner G
    Exp Clin Endocrinol; 1989; 94(3):239-43. PubMed ID: 2630306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
    Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
    Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of aminoglutethimide on steroid synthesis of the adrenal gland and its use in prostate cancer].
    Knönagel H; Hauri D
    Helv Chir Acta; 1989 Aug; 56(3):347-50. PubMed ID: 2807964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.